Blood Clots and Bleeding. MGUS. Nutrition. Elderly.
Dr. Pier Mannuccio Mannucci
▶⏸
1. Dr. Pier Mannuccio Mannucci. Hematology Expert. Biography. 0
Dr. Pier Mannucci, MD, explains advances in hemophilia and von Willebrand disease treatment. He discusses the genetic links between blood clots and undiagnosed cancer.
▶⏸
2. VITT. vaccine-induced thrombotic thrombocytopenia and COVID-19 vaccination. 11. [Parts 1 and 2]
Dr. Pier Mannucci, MD, explains the rare but serious condition of vaccine-induced thrombotic thrombocytopenia (VITT). He details the unique pathophysiology of VITT, which causes both...
▶⏸
3. Chronic liver disease. How to use laboratory tests correctly? 1
Dr. Pier Mannucci, MD, explains how to correctly interpret coagulation tests. He clarifies that abnormal prothrombin time does not predict bleeding risk in liver patients....
▶⏸
4. Blood clots risk and mutations. Do a genetic test or not? 4. [Parts 1 and 2]
Dr. Pier Mannucci, MD, explains the limited clinical utility of genetic testing for blood clot risk mutations. He details how common mutations like Factor V...
▶⏸
5. Personalized nutrition. How to choose real food well? 8. [Parts 1 and 2]
Dr. Pier Mannucci, MD, explains how personalized nutrition tailors diet to individual health risks. He emphasizes that food processing is more critical than macronutrient composition....
▶⏸
6. Air pollution and heart disease. How to lower your risks? 9. [Parts 1 and 2]
Dr. Pier Mannucci, MD, explores practical strategies for individuals to lower their personal exposure risks in urban environments, in conversation with
▶⏸
7. Polypharmacy in elderly patients. Why doctors prescribe too many drugs? 10. [Parts 1 and 2]
Dr. Pier Mannucci, MD, explains why elderly patients are prescribed too many medications. He details the severe risks of polypharmacy, including adverse drug events and...
▶⏸
8. Von Willebrand disease. New treatment options. MGUS. Acquired VWD. 2
Dr. Pier Mannuccio Mannucci, MD, covers the importance of specialist referral for accurate diagnosis. Von Willebrand disease is the most common inherited bleeding disorder.
▶⏸
9. Hemophilia. New treatment options. Emicizumab. Gene therapy. 3 [Part 1 and 2]
Dr. Anton Titov, MD, facilitates this in-depth discussion on precision medicine for hemophilia.
▶⏸
10. Deep vein thrombosis and cancer risk. Heparin and aspirin in DVT. 5
Dr. Pier Mannucci, MD, explains the complex relationship between cancer and blood clots. He details the use of low molecular weight heparin and direct oral...
▶⏸
11. Direct oral anticoagulants or vitamin K antagonists? When to use? 6
Dr. Pier Mannucci, MD, explains the advantages of direct oral anticoagulants over older vitamin K antagonists. He details the superior convenience and safety profile of...
▶⏸
12. Atrial fibrillation in elderly patients. Thrombosis vs. bleeding risk. 7
Dr. Pier Mannucci, MD, explains the critical balance between stroke prevention and bleeding risk in elderly atrial fibrillation patients. He emphasizes that stroke risk significantly...
▶⏸
13. MGUS and acquired von Willibrand syndrome. 12
Dr. Pier Mannucci, MD, explores the rare but serious complication of bleeding from acquired von Willebrand disease, in conversation with
Refine your treatment plan with a panel of top doctors who precisely fit your case.